Aim of the study is to perform a pilot study to assess the impact of Botulinum toxin on muscle tone, and caregiver burden in individuals who are cognitively impaired and who are fully dependent. The primary objective is to confirm proof of principle that paratonic rigidity and the consequences associated with it can be reduced with injection of Botulinum toxin injections resulting in reduced care-giver burden. The secondary objectives are to determine optimal time points for evaluation of efficacy in this patient population and whether the time period is sufficient for washout of Botulinum toxin effect; determine most salient and sensitive outcome measures; identify obstacles in data gathering; and lastly, to determine feasibility of battery of assessments in this pilot study.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
10
Assistive Technology Clinic at Baycrest
Toronto, Ontario, Canada
Impact on care-giver burden
Impact on caregiver burden in providing upper extremity care. Measured by the Carer Burden Scale which includes four items (cleaning the palm, cutting the fingernails, dressing, cleaning under the armpit). Each item rated on five point Likert scale ("no difficulty" to "cannot do task").
Time frame: 6 weeks for primary outcome, 32 weeks for entire study
Visual Analogue Scale
Completed by the professional caregiver that is caring for the patient to assess perception of ease of caregiving. Consists of 100 mm line with anchors of 0 "giving care to the residents is very difficult" and 100 "giving care to the residents is very easy"
Time frame: 6 weeks for secondary outcome, 32 weeks for entire study
Joint angle measurement
Joint angle measurements were used reflecting range of motion. Used as a surrogate measure for severity of paratonia
Time frame: 6 weeks for secondary outcome, 32 weeks for entire study
Pain
Pain Assessment in Advanced Dementia (PAINAD) Scale used to evaluate correlates of pain and determine whether Botulinum toxin treatment reduces discomfort of morning care. Consists of 5 items (breathing, negative vocalization, facial expression, body language and consolability), scored on a 0-2 point scale and then summed to arrive at a total scale.
Time frame: 6 weeks for secondary outcome, 32 weeks for entire study
Global Assessment
Overall response to treatment evaluated by study investigator and by professional caregiver caring for patient using the global assessment scale. A score of -4 indicates very marked worsening, 0 no change, and +4 very marked improvement.
Time frame: 6 weeks for secondary outcome, 32 weeks for entire study
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.